Scalp psoriasis

FDA approves label update of Cosentyx to include scalp psoriasis

9 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)

The FDA has approved a label update for Cosentyx, the first interleukin-17A inhibitor approved to treat moderate-to-severe plaque psoriasis...